Absci and AstraZeneca forge AI partnership to discover cancer treatments

Absci, a frontrunner in generative AI antibody discovery, has partnered with biopharmaceutical giant AstraZeneca to leverage AI in the quest for a novel cancer treatment.

This collaboration will capitalise on Absci's Integrated Drug Creation platform—seamlessly integrating with AstraZeneca's expertise in oncology, aiming to expedite the discovery of a potentially game-changing cancer therapy.

Under the agreement, Absci will deploy its pioneering generative AI...

4 December 2023 | Applications

AI is helping to make treatment for cancer more bearable

Researchers from MIT are using artificial intelligence to make treatment for cancer less debilitating but just as effective for patients. The AI learns from historical patient data to determine what the lowest doses and frequencies of medication delivered the desired results to shrink tumours. In some cases, the monthly administration of doses was reduced to just twice per year while achieving the same goal. Based on a trial of fifty patients, treatments were reduced to between a quarter and...

13 August 2018 | Healthcare

AI slashes cancer treatment plan creation to ‘mere hours’

Treating cancer is a race against time. Each moment which passes is an opportunity for it to spread and become untreatable. How long it takes for radiation therapy plans to be created today can take days. Individual maps need to be created for each patient to determine where tumours need to be targeted. This lengthy process is frustrating for the patient, their loved ones, and medical professionals who’d love nothing more than to spend time saving lives instead of creating...

2 August 2018 | Healthcare